Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.185
Bid: 0.17
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.03 (17.647%)
Open: 0.185
High: 0.00
Low: 0.00
Prev. Close: 0.185
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent

Mon, 07th Jun 2021 17:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Alba Mineral Resources PLC - mineral exploration and development company with assets in Greenland and the UK - Reports "significant" exploration target at Thule Black Sands ilmenite project in Greenland. Says independent exploration target of 70.0 million to 300.0 million tonnes of ilmenite at grade of 6% to 11%. "This would represent, at the lower end of the range, an almost three times increase in the current figures for contained ilmenite," Alba adds.

----------

Nuformix PLC - Cambridge, England-based pharmaceutical firm focused fibrosis and oncology - Gets notice of allowance in US for patent application numbered 17/051,592. The title of patent is "crystalline tranilast salts and their pharmaceutical use". CEP Anne Brindley says: "I am very pleased that we have received this Notice of Allowance from the US Patent Office meaning that this patent will proceed to be issued. This is an important endorsement of Nuformix's discoveries and also strengthens the patent estate for our lead asset NXP002."

----------

Destiny Pharma PLC - Brighton, England-based biotechnology firm - Notes discussions at G7 summit on global threat of antimicrobial resistance. "Destiny Pharma has been focused for many years on developing novel medicines from its XF platform that specifically address the AMR threat through the XF platform's unique mechanism of action which can provide safe, effective and fast acting treatments that do not generate resitance," Destiny says.

----------

Arecor Therapeutics PLC - Saffron Walden, England-based biopharmaceutical firm - Signs formulation study with Par Sterile Products LLC. Arecor will use proprietary formulation technology platform Arestat to help develop single dose formulation of an existing Par product.

----------

Omega Diagnostics Group PLC - sells wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics market - Updates on UK government Covid-19 test manufacturing contract. Says waiting for UK confirmation on what test it will manufacture. "Omega is not in control of this process and this is taking longer than originally expected but the company will provide a further update once a test is confirmed. The ability to supply tests that are produced within the UK remains a key priority for the [Department of Health & Social Care] and to that end the DHSC have facilitated initial commercial discussions between Omega and potential partner companies with lateral flow antigen tests to potentially provide UK manufacturing services," Omega adds.

----------

Landore Resources Ltd - Canada-focused minerals explorer - Says drilling in areas below and east of Bam gold project, Canada reported "wide zones of ore grade gold mineralisation". Chief Executive Bill Humphries says: "These encouraging results from relatively shallow intersections in the hanging wall of the extended east pit, together with the recently reported high grade drill intersections in the footwall, give promising indications of a substantial increase in the resource of the BAM gold deposit."

----------

Alien Metals Ltd - iron ore and silver projects in Australia and Mexico - Receives results from maiden drilling programme at Hancock iron ore project, Australia. Results confirm four "high grade direct shipping ore mineralisation prospects", Alien adds.

----------

Adriatic Metals PLC - developing Vares silver project in Bosnia & Herzegovina - Secures exploration permit of concessions granted last year at Vares. Allows drilling and channel sampling to commence, Adriatic adds.

----------

Ferro-Alloy Resources Ltd - developer of Balasausqandiq vanadium deposit in Kazakhstan - Initial investment from Vision Blue Resources completed. "The company has now received the further investment of USD1.6 million in addition to the investment of USD1.5 million already made, bringing the total invested by Vision Blue and its coinvestors to date to USD3.1 million," company says.

----------

AEX Gold Inc - Greenland-focused gold miner - Says team of geologists and drilling engineers arrive at Nalunaq project, Greenland. Team is there to "to further develop the company's understanding of the area to the south west of the deposit," AEX adds.

----------

Panther Metals PLC - company focused on mineral exploration in Canada and Australia - Applies to acquire two tenements, E39/2249 and E39/2250, as part of expansion programme at Red Flag nickel and cobalt asset.

----------

Challenger Energy Group PLC - Caribbean and Atlantic margin focused oil & gas company - Granted three month extension to report results for year ended December 31, 2020. Expects to publish results by September 30.

----------

Accsys Technologies PLC - wood building products manufacturer - Receives notice from Engie Fabricom UK Ltd to terminate engineering, procurement and construction agreement at Tricoya plant in Hull. Accsys says termination notice down to "force majeure arising out of the Covid-19 pandemic and stating that they plan to demobilise over the next two weeks". Accsys adds: "The purported termination may now result in Tricoya UK taking over earlier than previously anticipated the completion of the final stages of construction and subsequent commissioning. This may be with or without assistance of a new lead contractor given the advanced status of the project."

----------

Windar Photonics PLC - London-based developer of wind sensors for electricity generating wind turbines - In four year development project focused on drone based emission detection system. "The development project, which brings together five private companies and the Technical University of Denmark, has a total budget of EUR2.2 million and is backed by a public grant of EUR1.7 million from the Innovation Fund Denmark, under its Grand Solutions programme," Windar adds.

----------

Tungsten Corp PLC - digital financial management products and software solutions provider - Picked by "global human resources software leader" to support its e-invoicing plans in Europe and US. "The customer's 16 European entities will use Tungsten's Total AR solution to streamline and digitise its accounts receivable processes. In the US, the solution will allow the customer to send invoices to its customers via the Tungsten Network, eliminating manual invoice entry systems," Tungsten adds.

----------

Blue Star Capital PLC - esports, payments and technology focused investor - Investee SatoshiPay receives research and development grant from Stellar Development Foundation. "In its blog, SatoshiPay advises that the Stellar Foundation grant will be used to kickstart the development of the Pendulum network project and develop a proof-of-concept implementation of Pendulum," Blue Star says.

----------

Seeing Machines Ltd - Canberra-based driver-monitoring technology company - Notes US 21st Century Smart Cars Act. "These developments in the US are completely aligned to Seeing Machines' view that [mandatory driver monitoring system] is fundamental to the automotive transport sector and that the fitment rate will accelerate substantially over the coming years, globally. Seeing Machines is currently working with all major US automotive manufacturers to deliver its industry-leading technology, with some of these vehicles already in production and on sale to consumers today, fitted with camera-based DMS," company says.

----------

UniVision Engineering Ltd - Hong Kong-based supply, design, installation and maintenance of closed circuit television and surveillance systems - Deal for Chair Stephen Koo to sell 201.0 million shares, 52.4% stake, in UniVision to SinoCloud Group Ltd will not proceed. "The proposed transaction had been subject to a number of pre-conditions. The parties have held various discussions since the signing of the MOU, but these discussions did not produce a definitive agreement within the three-month exclusivity period contained in the MOU," company adds.

----------

Centaur Media PLC - business information, events and marketing provider - Says Jane Wilkinson to succeed Andy Baker as managing director of The Lawyer, Centaur's unit which provides business intelligence to UK legal market. Baker steps down on July 31, Wilkinson takes up role on August 2. "In her role as managing director, Jane Wilkinson will bring deep expertise in subscription revenue modelling and leading businesses in times of digital and data transformation. She will be responsible for developing The Lawyer's customer-centric approach and building on its recent transition into a multi-channel digital platform as part of Centaur's MAP23 strategy," company adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Mar 2024 14:30

UK shareholder meetings calendar - next 7 days

Wednesday 13 March 
abrdn China Investment Co LtdGM re liquidation
Safestore Holdings PLCAGM
Wincanton PLCGM re takeover by CEVA Logistics
Thursday 14 March 
Angus Energy PLCGM
Bank of Georgia Group PLCGM re acquisition of Ameriabank CJSC
Blackrock Sustainable American Income Trust PLCAGM
Friday 15 March 
BlackRock Energy & Resources Income Trust PLCAGM
Chrysalis Investments LtdAGM
Quantum Exponential Group PLCGM re delisting from AQSE
TruSpine Technologies PLCAGM (adjourned 2022)
United Oil & Gas PLCGM re fundraise and share sub-division
Monday 18 March 
MGC Pharmaceuticals LtdGM re change of company name to Argent Biopharma
Schroder European Real Estate Investment Trust PLCAGM
Tuesday 19 March 
BlackRock Throgmorton Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Eco Animal Health Group PLCGM re share buybacks
Gresham House Renewable Energy VCT 1 PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
Nuformix PLCAGM
Scirocco Energy PLCGM re requisitioned resolution to implement cash strategy
Various Eateries PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
1 Mar 2024 10:31

IN BRIEF: Nuformix announces subscription to raise GBP150,000

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross proceeds of GBP150,000 through a subscription for 75.0 million new shares at a price of 0.20 pence each. The shares will represent 9.2% of Nuformix's enlarged issued share capital. Company will use the subscription's net proceeds primarily to further advance its NXP002 programme for the inhaled treatment of idiopathic pulmonary fibrosis.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
23 Oct 2023 12:38

Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002

(Alliance News) - Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatment for idiopathic pulmonary fibrosis.

Read more
18 Sep 2023 10:20

IN BRIEF: Nuformix to receive milestone payments from Oxilio pact

Nuformix PLC - London-based pharmaceutical development company targeting unmet medical needs in fibrosis and oncology - Says it will receive immediate and near-term milestone payments as part of an update to its NXP001 exclusive licensing agreement with Oxilio Ltd. Nuformix does not disclose any financial details on this. Under the revised agreement, says Oxilio will acquire ownership of Nuformix's NXP001 patent estate. Says it will receive the additional milestone payments while retaining further development milestones and royalties capped at GBP2 million per year.

Read more
17 Aug 2023 15:43

UK shareholder meetings calendar - next 7 days

Friday 18 August 
Adams PLCAGM
ME Group International PLCGM re proposed share buyback
Oxford BioDynamics PLCGM re placing
Pathfinder Minerals PLCGM re disposal of the subsidiary
Monday 21 August 
Calculus VCT PLCAGM
Home REIT PLCGM re changes to the investment policy
Tuesday 22 August 
Cake Box Holdings PLCAGM
ReNeuron Group PLCAGM
RUA Life Sciences PLCAGM
Smoove PLCAGM
STM Group PLCAGM
Wednesday 23 August 
Brandshield Systems PLCAGM
James Latham PLCAGM
LifeSafe Holdings PLCGM re shareholder circular
Momentum Multi-Asset Value Trust PLCGM re appointment of the liquidators
Sovereign Metals LtdGM re share placement options
Thor Energy PLCGM re proposed share consolidation
Thursday 24 August 
Ananda Developments PLCAGM
Concurrent Technologies PLCAGM
CyanConnode Holdings PLCAGM
Nuformix PLCAGM
Oryx International Growth Fund LtdAGM
ThomasLloyd Energy Impact Trust PLCAGM
ThomasLloyd Energy Impact Trust PLCGM re market purchases of its own ordinary shares
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 May 2023 12:45

Nuformix loss narrows; near-term goal to focus on NXP002 asset

(Alliance News) - Nuformix PLC on Monday reported a narrowed annual loss as it made progress on optimising costs and furthering its lead asset, NXP002.

Read more
18 May 2023 14:31

TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
17 Apr 2023 12:14

Nuformix raises GBP70,000 to fund NXP002 programme

(Alliance News) - Nuformix PLC on Monday said it has raised GBP70,000 through a subscription for 35.0 million new shares at a price of 0.20 pence each.

Read more
27 Mar 2023 18:42

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
15 Feb 2023 12:12

Nuformix progresses NXP002 trial after acquiring human tissue

(Alliance News) - Nuformix PLC on Wednesday said that, despite having to wait longer than expected, human disease tissue has now been acquired for its NXP002 programme.

Read more
13 Dec 2022 14:54

Nuformix interim loss virtually flat as continues work on drugs

(Alliance News) - Nuformix PLC on Tuesday reported a negligibly smaller half-year loss as it continued to work on treatments for cancer and fibrosis, a disease which scars tissues in the lungs.

Read more
23 Sep 2022 21:02

TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Aug 2022 16:01

UK shareholder meetings calendar - next 7 days

Friday 19 August 
Braemar Shipping Services PLCAGM
Citius Resources PLCAGM
Next Fifteen Communications Group PLCGM re acquisition of M&C Saatchi
Volex PLCAGM
Monday 22 August 
African Pioneer PLCAGM
Argentex Group PLCAGM
Nostrum Oil & Gas PLCGM operational update
Ondo InsurTech PLCAGM
Sabien Technology Group PLCGM re broker option
Scottish Investment Trust PLCGM re recombination of assets with JPMorgan Global Growth & Income plc
Trackwise Designs PLCAGM
Tuesday 23 August 
Bezant Resources PLCAGM
Livermore Investments Group LtdAGM
Xtract Resources PLCAGM
Wednesday 24 August 
Amur Minerals CorpGM subsidiary sale
Creightons PLCAGM
Goldstone Resources LtdAGM
Thursday 25 August 
Ince Group PLCGM fundraising
McBride PLCGM increase in borrowing limit
NatWest Group PLCGM re approval of special dividend
Nuformix PLCAGM
Triple Point Energy Efficiency Infrastructure Co PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
10 Aug 2022 11:14

IN BRIEF: Nuformix shares rise on tolerability studies completion

Nuformix PLC - London-based pharmaceutical firm targeting fibrosis and oncology - Says NXP002, a potential treatment for idiopathic pulmonary fibrosis, has successfully completed pre-clinical tolerability studies. "Tolerability has been demonstrated across a new range of doses, including higher doses than previously given," it explains. Work now commences to explore how the new doses studied can best optimise efficacy and the treatment's positive pharmacological profile.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.